Zydus receives final approval from the USFDA for Febuxostat Tablets

Zydus receives final approval from the USFDA for Febuxostat Tablets

The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India.

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 03:14 PM IST
article-image
Zydus receives final approval from the USFDA for Febuxostat Tablets | File/ Representative image

Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug Administration (USFDA) to market Febuxostat Tablets, 40 mg and 80 mg (USRLD: Uloric Tablets).

Febuxostat tablets are indicated to lower hyperuricemia (high uric acid in the blood) in patients with gout who have been treated with allopurinol that did not work well or cannot be treated with allopurinol. The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India.

Febuxostat tablets had annual sales of USD 32 million in the United States according to IQVIA data (IQVIA MAT Sept. 2022).

The group now has 340 approvals and has so far filed over 431* ANDAs since the commencement of the filing process in FY 2003-04.

RECENT STORIES

Microsoft Exits Pakistan After 26 Years, Major Blow To Tech Ecosystem

Microsoft Exits Pakistan After 26 Years, Major Blow To Tech Ecosystem

Telangana Government's Big Decision On Work Hours, Now Only This Much Work Required Daily

Telangana Government's Big Decision On Work Hours, Now Only This Much Work Required Daily

PM-Kisan 20th Installment Likely On This Date, Here's How To Check Your Status

PM-Kisan 20th Installment Likely On This Date, Here's How To Check Your Status

Public Sector Banks To Recruit 50,000 Staff In FY26 Amid Growth Push; SBI To Hire 20,000 Alone

Public Sector Banks To Recruit 50,000 Staff In FY26 Amid Growth Push; SBI To Hire 20,000 Alone

'India Needs 10 Percent Nominal GDP Growth Annually To Meet Viksit Bharat Goal By 2047,' Says CII...

'India Needs 10 Percent Nominal GDP Growth Annually To Meet Viksit Bharat Goal By 2047,' Says CII...